date:May 10, 2012
e to the groups lawsuit, FDA acknowledged that there are differences between nanomaterials and their bulk counterparts, and the nanomaterials have potential new risks and may require new testing, said the groups statement.
However, the agency declined to enact mandatory regulations at this time.
Despite already being commercially available, nanomaterials in sunscreens, cosmetics, foods and food contact substances are unlabelled and largely untested and largely untested for their human health